Emotionally Responsive Virtual Coach Helps Address Patient Concerns in New Simulation
Kognito, a health simulation company, is applying its simulation technology to patient education, to address a gap in patient knowledge.
Breast Cancer
Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors
Tied to improvements in pain, anxiety, depression among breast cancer survivors with fatigue
Trazimera, a Biosimilar to Herceptin, Gets FDA Approval
The FDA has approved Trazimera (trastuzumab-qyyp; Pfizer), a biosimilar to Herceptin (trastuzumab; Genentech).
First Cancer Immunotherapy Regimen Approved for Breast Cancer Treatment
The Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq (atezolizumab; Genentech) in combination with Abraxane.
Herceptin Hylecta Approved for the Treatment of HER2-Overexpressing Breast Cancer
The Food and Drug Administration (FDA) has approved Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for the treatment of HER2-overexpressing breast cancer.
FDA: Thermography No Substitute for Mammograms
Despite claims to the contrary, thermography should not be used in place of mammography for breast cancer screening, detection, or diagnosis, according to the US Food and Drug Administration.
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients.
USPSTF Says Screen Women With Higher Risk for BRCA Mutations
The USPSTF recommends screening for women at increased risk for carrying a BRCA1/2 mutation as well as genetic counseling and testing as indicated for those screening positive.
Long-Term Incidence of A-Fib Increased in Women With Breast Cancer
Breast cancer was associated with an increased incidence of AF during the first 6 months and from 6 months to 3 years for patients younger than 60 years (hazard ratios, 2.1 [95% confidence interval, 1.25 to 3.44] and 1.8 [95% confidence interval, 1.38 to 2.35], respectively).
Biosimilar Cancer Treatment Ontruzant Gets FDA Approval
Prior to treatment, HER2 testing using FDA-approved tests should be performed.
